These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Islam MA, Pillay TS. J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527 [Abstract] [Full Text] [Related]
3. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors. Fatemi MH, Heidari A, Gharaghani S. J Theor Biol; 2015 Mar 21; 369():13-22. PubMed ID: 25600056 [Abstract] [Full Text] [Related]
7. Characterization of small molecule binding. I. Accurate identification of strong inhibitors in virtual screening. Ding B, Wang J, Li N, Wang W. J Chem Inf Model; 2013 Jan 28; 53(1):114-22. PubMed ID: 23259763 [Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands. Yang ZH, Bai XG, Zhou L, Wang JX, Liu HT, Wang YC. Bioorg Med Chem Lett; 2015 May 01; 25(9):1880-3. PubMed ID: 25838144 [Abstract] [Full Text] [Related]
14. Pocket-to-Lead: Structure-Based De Novo Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a Template. Kojima E, Iimuro A, Nakajima M, Kinuta H, Asada N, Sako Y, Nakata Z, Uemura K, Arita S, Miki S, Wakasa-Morimoto C, Tachibana Y. J Med Chem; 2022 Apr 28; 65(8):6157-6170. PubMed ID: 35416651 [Abstract] [Full Text] [Related]
15. Enhanced replication of R5 HIV-1 isolates in vitro by a small-molecule reagent targeting HIV-1 protease. Wardle NJ, Hudson HR, Matthews RW, Nunn CM, Vella C, Bligh SW. ChemMedChem; 2013 May 28; 8(5):719-21. PubMed ID: 23509042 [Abstract] [Full Text] [Related]